<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="and Sons Inc.Hoboken pmcid: 7262150 doi: 10.1111/jce.14479JCE14479 : Review: Review" exact="Cardiac" post="and arrhythmic complications in patients with COVIDâ€�19 KOCHI et"/>
 <result pre="al. KochiAdriano NunesMD, MSchttp://orcid.org/0000-0002-7839-20541adrianokochi@gmail.comTagliariAna PaulaMD, MSc2ForleoGiovanni BattistaMD, PhDhttp://orcid.org/0000-0001-8895-89153FassiniGaetano MicheleMD1TondoClaudioMD, PhD14[1]," exact="Heart" post="Rhythm CenterCentro Cardiologico Monzino IRCCSMilanItaly[2], Cardiovascular Surgery DepartmentUniversity Hospital"/>
 <result pre="Community HealthUniversity of MilanMilanItaly *Correspondence Adriano Nunes Kochi, MD, MSc," exact="Heart" post="Rhythm Center, Centro Cardiologico Monzino IRCCS, Via Carlo Parea,"/>
 <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="world started to face a new pandemic situation, the severe" exact="acute" post="respiratory syndromeâ€�coronavirus 2 (SARSâ€�CoVâ€�2). Although coronavirus disease (COVIDâ€�19) clinical"/>
 <result pre="started to face a new pandemic situation, the severe acute" exact="respiratory" post="syndromeâ€�coronavirus 2 (SARSâ€�CoVâ€�2). Although coronavirus disease (COVIDâ€�19) clinical manifestations"/>
 <result pre="situation, the severe acute respiratory syndromeâ€�coronavirus 2 (SARSâ€�CoVâ€�2). Although coronavirus" exact="disease" post="(COVIDâ€�19) clinical manifestations are mainly respiratory, major cardiac complications"/>
 <result pre="manifestations are mainly respiratory, major cardiac complications are being reported." exact="Cardiac" post="manifestations etiology seems to be multifactorial, comprising direct viral"/>
 <result pre="reported. Cardiac manifestations etiology seems to be multifactorial, comprising direct" exact="viral" post="myocardial damage, hypoxia, hypotension, enhanced inflammatory status, ACE2â€�receptors downregulation,"/>
 <result pre="an appraisal of other virus epidemics as SARSâ€�CoV, Middle East" exact="respiratory" post="syndrome coronavirus, and H1N1 influenza. arrhythmia COVIDâ€�19 myocardial damage"/>
 <result pre="appraisal of other virus epidemics as SARSâ€�CoV, Middle East respiratory" exact="syndrome" post="coronavirus, and H1N1 influenza. arrhythmia COVIDâ€�19 myocardial damage myocarditis"/>
 <result pre="as SARSâ€�CoV, Middle East respiratory syndrome coronavirus, and H1N1 influenza." exact="arrhythmia" post="COVIDâ€�19 myocardial damage myocarditis SARSâ€�CoVâ€�2 fig-count: table-count: page-count: word-count:"/>
 <result pre="respiratory syndrome coronavirus, and H1N1 influenza. arrhythmia COVIDâ€�19 myocardial damage" exact="myocarditis" post="SARSâ€�CoVâ€�2 fig-count: table-count: page-count: word-count: KochiAN, TagliariAP, ForleoGB, FassiniGM,"/>
 <result pre="J Cardiovasc Electrophysiol. 2020;31:1003â€&quot;1008. 10.1111/jce.1447932270559 Abbreviations ATP antitachycardia pacing CHF" exact="congestive heart failure" post="CO cardiac output COVIDâ€�19 coronavirus diseaseâ€�2019 CRTâ€�D cardiac resynchronization"/>
 <result pre="Cardiovasc Electrophysiol. 2020;31:1003â€&quot;1008. 10.1111/jce.1447932270559 Abbreviations ATP antitachycardia pacing CHF congestive" exact="heart" post="failure CO cardiac output COVIDâ€�19 coronavirus diseaseâ€�2019 CRTâ€�D cardiac"/>
 <result pre="coronavirus diseaseâ€�2019 CRTâ€�D cardiac resynchronization therapy defibrillator HCQ hydroxychloroquine HF" exact="heart" post="failure HR hazard ratio hsâ€�cTnI highâ€�sensitivity cardiac troponin I"/>
 <result pre="care unit LVEF left ventricular ejection fraction MERSâ€�CoV Middle East" exact="respiratory" post="syndrome coronavirus NHC National Health Commission of China OR"/>
 <result pre="unit LVEF left ventricular ejection fraction MERSâ€�CoV Middle East respiratory" exact="syndrome" post="coronavirus NHC National Health Commission of China OR odds"/>
 <result pre="NHC National Health Commission of China OR odds ratio RBBB" exact="right bundle branch block" post="SARS severe acute respiratory syndrome SARSâ€�CoV severe acute respiratory"/>
 <result pre="OR odds ratio RBBB right bundle branch block SARS severe" exact="acute" post="respiratory syndrome SARSâ€�CoV severe acute respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe"/>
 <result pre="odds ratio RBBB right bundle branch block SARS severe acute" exact="respiratory" post="syndrome SARSâ€�CoV severe acute respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe acute"/>
 <result pre="ratio RBBB right bundle branch block SARS severe acute respiratory" exact="syndrome" post="SARSâ€�CoV severe acute respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe acute respiratory"/>
 <result pre="bundle branch block SARS severe acute respiratory syndrome SARSâ€�CoV severe" exact="acute" post="respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe acute respiratory syndromeâ€�coronavirus 2 SCD"/>
 <result pre="branch block SARS severe acute respiratory syndrome SARSâ€�CoV severe acute" exact="respiratory" post="syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe acute respiratory syndromeâ€�coronavirus 2 SCD sudden"/>
 <result pre="acute respiratory syndrome SARSâ€�CoV severe acute respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe" exact="acute" post="respiratory syndromeâ€�coronavirus 2 SCD sudden cardiac death SVT supraventricular"/>
 <result pre="respiratory syndrome SARSâ€�CoV severe acute respiratory syndromeâ€�coronavirus SARSâ€�CoVâ€�2 severe acute" exact="respiratory" post="syndromeâ€�coronavirus 2 SCD sudden cardiac death SVT supraventricular tachycardia"/>
 <result pre="SVT supraventricular tachycardia TnT troponin T VA ventricular arrhythmias VF" exact="ventricular fibrillation" post="VT ventricular tachycardia 1 INTRODUCTION Since the last December,"/>
 <result pre="supraventricular tachycardia TnT troponin T VA ventricular arrhythmias VF ventricular" exact="fibrillation" post="VT ventricular tachycardia 1 INTRODUCTION Since the last December,"/>
 <result pre="TnT troponin T VA ventricular arrhythmias VF ventricular fibrillation VT" exact="ventricular tachycardia" post="1 INTRODUCTION Since the last December, the entire world"/>
 <result pre="entire world is facing a new pandemic situation, the severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2). After emerging from Wuhanâ€�China,"/>
 <result pre="world is facing a new pandemic situation, the severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARSâ€�CoVâ€�2). After emerging from Wuhanâ€�China, the"/>
 <result pre="is facing a new pandemic situation, the severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2). After emerging from Wuhanâ€�China, the coronavirus"/>
 <result pre="factors, physicians are passing through realâ€�time learning process. As the" exact="disease" post="spreads, a massive wave of information takes over scientific"/>
 <result pre="and media. This new virus belongs to the same severe" exact="acute" post="respiratory syndromeâ€�coronavirus (SARSâ€�CoV) and Middle East respiratory syndromeâ€�coronavirus (MERSâ€�CoV)"/>
 <result pre="media. This new virus belongs to the same severe acute" exact="respiratory" post="syndromeâ€�coronavirus (SARSâ€�CoV) and Middle East respiratory syndromeâ€�coronavirus (MERSâ€�CoV) family."/>
 <result pre="the same severe acute respiratory syndromeâ€�coronavirus (SARSâ€�CoV) and Middle East" exact="respiratory" post="syndromeâ€�coronavirus (MERSâ€�CoV) family. Although COVIDâ€�19 clinical manifestations are mainly"/>
 <result pre="a considerable number of patients with COVIDâ€�19.1, 2, 3 SARSâ€�CoVâ€�2" exact="infection" post="is associated with a variety of proâ€�inflammatory mediators that"/>
 <result pre="was observed, during these outbreaks, a significant association between underlying" exact="cardiovascular disease," post="myocardial injury, and worse outcomes.4 The first human infection"/>
 <result pre="cardiovascular disease, myocardial injury, and worse outcomes.4 The first human" exact="infection" post="by a new strain of coronavirus, the SARSâ€�CoV, was"/>
 <result pre="time it was known that, at least in rabbits, coronavirus" exact="infections" post="could induce cardiomyopathy resulting in cardiac chambers dilatation and"/>
 <result pre="known that, at least in rabbits, coronavirus infections could induce" exact="cardiomyopathy" post="resulting in cardiac chambers dilatation and systolic function impairment,"/>
 <result pre="in cardiac chambers dilatation and systolic function impairment, simulating other" exact="dilated" post="cardiomyopathies.5 In humans, hypotension, cardiac arrhythmias, and even sudden"/>
 <result pre="YuÂ et al demonstrated that sinus tachycardia was the commonest" exact="cardiovascular" post="SARSâ€�CoV finding with an overall incidence of 72%. Persistent"/>
 <result pre="Persistent tachycardia mean duration was 12.7 days with a mean" exact="heart" post="rate of 117 beats/min (range:Â 102â€�150 beats/min) and the"/>
 <result pre="be due to autonomic tone changing. Or, alternatively, sinus tachycardia" exact="secondary" post="to cardiopulmonary or peripheral deconditioning since this disease resulted"/>
 <result pre="tone changing. Or, alternatively, sinus tachycardia secondary to cardiopulmonary or" exact="peripheral" post="deconditioning since this disease resulted in prolonged bed rest.7"/>
 <result pre="sinus tachycardia secondary to cardiopulmonary or peripheral deconditioning since this" exact="disease" post="resulted in prolonged bed rest.7 Besides these findings, significant"/>
 <result pre="(14.9%) patients. Unlike tachycardia, which was persistent, bradycardia was somewhat" exact="transient" post="with a mean heart rate of 43 beats/min (range:Â"/>
 <result pre="which was persistent, bradycardia was somewhat transient with a mean" exact="heart" post="rate of 43 beats/min (range:Â 38â€�49 beats/min) and a"/>
 <result pre="38â€�49 beats/min) and a mean duration of 2.6 days. Reversible" exact="cardiomegaly" post="was also reported in 13 (10.7%), with no clinical"/>
 <result pre="also reported in 13 (10.7%), with no clinical evidence of" exact="heart" post="failure (HF). Transient atrial fibrillation was observed in one"/>
 <result pre="13 (10.7%), with no clinical evidence of heart failure (HF)." exact="Transient" post="atrial fibrillation was observed in one patient.7 LauÂ et"/>
 <result pre="(10.7%), with no clinical evidence of heart failure (HF). Transient" exact="atrial fibrillation" post="was observed in one patient.7 LauÂ et al additionally"/>
 <result pre="with no clinical evidence of heart failure (HF). Transient atrial" exact="fibrillation" post="was observed in one patient.7 LauÂ et al additionally"/>
 <result pre="from SARS. Possible causes, according to them, were deconditioning, impaired" exact="pulmonary" post="function, impaired cardiac function, cardiac arrhythmia, thyroid dysfunction, anemia,"/>
 <result pre="to them, were deconditioning, impaired pulmonary function, impaired cardiac function," exact="cardiac arrhythmia," post="thyroid dysfunction, anemia, autonomic dysfunction, and anxiety state.8 Trying"/>
 <result pre="cardiac function, cardiac arrhythmia, thyroid dysfunction, anemia, autonomic dysfunction, and" exact="anxiety" post="state.8 Trying to explain the occurrence of cardiac arrest"/>
 <result pre="dysfunction, and anxiety state.8 Trying to explain the occurrence of" exact="cardiac arrest" post="in 15 patients with SARS, Pan et al suggested"/>
 <result pre="causing new myocardial cells and/or conduction system damage; (c) SARS" exact="infection" post="aggravating preâ€�existing myocardial conditions, or conduction disturbances; and (d)"/>
 <result pre="aggravating preâ€�existing myocardial conditions, or conduction disturbances; and (d) extreme" exact="anxiety" post="leading to further endogenous catecholamine release, causing myocardial electrical"/>
 <result pre="1 Mechanisms and consequences of COVIDâ€�19 myocardial damage. COVIDâ€�19, coronavirus" exact="disease" post="In the setting of the 2012Â MERSâ€�CoV syndrome, despite"/>
 <result pre="mortality rate was about 10%.11 A metaâ€�analysis suggested that MERSâ€�CoV" exact="infection" post="was more likely to occur in patients with underlying"/>
 <result pre="infection was more likely to occur in patients with underlying" exact="cardiovascular" post="diseases.12 In terms of overall complications, renal failure (40.9%),"/>
 <result pre="patients with underlying cardiovascular diseases.12 In terms of overall complications," exact="renal failure" post="(40.9%), cardiac arrhythmias (15.7%), hepatic dysfunction (31.4%),13 besides pericarditis,"/>
 <result pre="In a case report published by Alhogbani, he describes an" exact="acute" post="myocarditis caused by MERSâ€�CoV; a 60â€�yearâ€�old presenting with respiratory"/>
 <result pre="a case report published by Alhogbani, he describes an acute" exact="myocarditis" post="caused by MERSâ€�CoV; a 60â€�yearâ€�old presenting with respiratory symptoms,"/>
 <result pre="an acute myocarditis caused by MERSâ€�CoV; a 60â€�yearâ€�old presenting with" exact="respiratory" post="symptoms, chest pain, and persistent tachycardia (120â€‰bpm). Echocardiogram demonstrated"/>
 <result pre="myocarditis caused by MERSâ€�CoV; a 60â€�yearâ€�old presenting with respiratory symptoms," exact="chest" post="pain, and persistent tachycardia (120â€‰bpm). Echocardiogram demonstrated severe left"/>
 <result pre="ventricularÂ function impairment, cardiac magnetic resonance showed typical findings of" exact="acute" post="myocarditis, and sputum was positive for MERSâ€�CoV. The patient"/>
 <result pre="and 1 month of ward hospitalization, he was discharged in" exact="stable" post="condition.15 Last but not least, influenza virus infection is"/>
 <result pre="was discharged in stable condition.15 Last but not least, influenza" exact="virus infection" post="is wellâ€�known to aggravate plenty of cardiovascular disorders, being"/>
 <result pre="discharged in stable condition.15 Last but not least, influenza virus" exact="infection" post="is wellâ€�known to aggravate plenty of cardiovascular disorders, being"/>
 <result pre="least, influenza virus infection is wellâ€�known to aggravate plenty of" exact="cardiovascular" post="disorders, being associated with myocarditis, myocardial infarction, and HF"/>
 <result pre="to aggravate plenty of cardiovascular disorders, being associated with myocarditis," exact="myocardial infarction," post="and HF exacerbation.16 An interesting survey conducted by MadjidÂ"/>
 <result pre="other periods of the year, suggesting a correlation between higher" exact="arrhythmia" post="burden and influenza season. The multivariate generalized linear model"/>
 <result pre="VA treated with shock (odds ratio [OR]:Â 1.06; Pâ€‰ Pâ€‰17" exact="Multiple" post="mechanisms have been proposed to explain influenza triggering arrhythmias,"/>
 <result pre="of the most plausible. Moreover, influenza is known to exacerbate" exact="congestive heart failure" post="(CHF) and increase CHFâ€�related hospital admissions.18 Decompensated CHF, besides"/>
 <result pre="the most plausible. Moreover, influenza is known to exacerbate congestive" exact="heart" post="failure (CHF) and increase CHFâ€�related hospital admissions.18 Decompensated CHF,"/>
 <result pre="therapy. In patients with underlying ischemic cardiomyopathy, the worsening of" exact="ischemia" post="by increased oxygen demand and potential acute coronary syndromes"/>
 <result pre="the worsening of ischemia by increased oxygen demand and potential" exact="acute" post="coronary syndromes led by influenza can also have a"/>
 <result pre="allâ€�cause death and 18% reduction in the adjusted risk of" exact="cardiovascular" post="death (Pâ€‰ Pâ€‰=â€‰.009). According to this study, influenza infection"/>
 <result pre="of cardiovascular death (Pâ€‰ Pâ€‰=â€‰.009). According to this study, influenza" exact="infection" post="may result in increased metabolic demand, hypoxia, and adrenergic"/>
 <result pre="metabolic demand, hypoxia, and adrenergic surges, which may lead to" exact="acute" post="decompensation or exacerbation of HF. Additionally, the infection may"/>
 <result pre="lead to acute decompensation or exacerbation of HF. Additionally, the" exact="infection" post="may induce a hypercoagulable state and trigger acute coronary"/>
 <result pre="Additionally, the infection may induce a hypercoagulable state and trigger" exact="acute" post="coronary syndromes, resulting in further left ventricular function deterioration,"/>
 <result pre="strategy to improve survival in patients with HF.19 1.2 Coronavirus" exact="disease" post="Despite not being particularly lethal, SARSâ€�CoVâ€�2 is very contagious."/>
 <result pre="published clinical cohort of patients with COVIDâ€�19, they observed that" exact="acute" post="cardiac injury, shock, and arrhythmias were present in 7.2%,"/>
 <result pre="suggesting that patients with severe symptoms often have complications involving" exact="acute" post="myocardial injury.2 Overall, arrhythmia rate was also more frequent"/>
 <result pre="severe symptoms often have complications involving acute myocardial injury.2 Overall," exact="arrhythmia" post="rate was also more frequent in ICU patients (44.4%"/>
 <result pre="MERSâ€�CoV, H1N1, and SARSâ€�CoVâ€�2 First author, y Number of patients" exact="Cardiac" post="manifestations Troponin Inâ€�hospital mortality SARSâ€�CoV LeeÂ et al39 138"/>
 <result pre="Cardiac manifestations Troponin Inâ€�hospital mortality SARSâ€�CoV LeeÂ et al39 138" exact="Acute" post="HF (1â€‰pt) None 3.6% Booth etÂ al40 144 Pulse"/>
 <result pre="control: Lower LVEF Lower dopplerâ€�derived CO YuÂ et al7 121" exact="Tachycardia" post="(71.9%) ND ND Hypotension (50.4%) Bradycardia (14.9%) Rev cardiomegaly"/>
 <result pre="dopplerâ€�derived CO YuÂ et al7 121 Tachycardia (71.9%) ND ND" exact="Hypotension" post="(50.4%) Bradycardia (14.9%) Rev cardiomegaly (10.7%) MERSâ€�CoV SaadÂ et"/>
 <result pre="121 Tachycardia (71.9%) ND ND Hypotension (50.4%) Bradycardia (14.9%) Rev" exact="cardiomegaly" post="(10.7%) MERSâ€�CoV SaadÂ et al13 70 Arrhythmias (15.7%) ND"/>
 <result pre="Bradycardia (14.9%) Rev cardiomegaly (10.7%) MERSâ€�CoV SaadÂ et al13 70" exact="Arrhythmias" post="(15.7%) ND 60% Alâ€�TawfiqÂ et al41 17 Xâ€�ray cardiomegaly"/>
 <result pre="70 Arrhythmias (15.7%) ND 60% Alâ€�TawfiqÂ et al41 17 Xâ€�ray" exact="cardiomegaly" post="(53%) ND 76% Chest pain (7%) Assiri et al43"/>
 <result pre="pain (44%) ND 22% Pericarditis (1â€‰pt) VT (1â€‰pt) SVT (1â€‰pt)" exact="H1N1 Influenza" post="Schoen et al42 160 Chest pain (5%) ND Zero"/>
 <result pre="Chest pain (5%) ND Zero SARSâ€�CoVâ€�2 Huang et al20 41" exact="Shock" post="(7%) Elevated in 12.2% 15% Wang et al2 118"/>
 <result pre="(5%) ND Zero SARSâ€�CoVâ€�2 Huang et al20 41 Shock (7%)" exact="Elevated" post="in 12.2% 15% Wang et al2 118 Arrhythmia (16.7%)"/>
 <result pre="Shock (7%) Elevated in 12.2% 15% Wang et al2 118" exact="Arrhythmia" post="(16.7%) Mean 6.4â€‰pg/mL 4.3% Shock (8.7%) Acute cardiac injury"/>
 <result pre="15% Wang et al2 118 Arrhythmia (16.7%) Mean 6.4â€‰pg/mL 4.3%" exact="Shock" post="(8.7%) Acute cardiac injury (7.2%) Shi et al1 416"/>
 <result pre="et al2 118 Arrhythmia (16.7%) Mean 6.4â€‰pg/mL 4.3% Shock (8.7%)" exact="Acute" post="cardiac injury (7.2%) Shi et al1 416 Chest pain"/>
 <result pre="cardiac injury (7.2%) Shi et al1 416 Chest pain (3.4%)" exact="Elevated" post="in 19.7% 13.7% STâ€�depression on ECG (0.7%) Zhou et"/>
 <result pre="STâ€�depression on ECG (0.7%) Zhou et al22 191 HFÂ (23%)" exact="Elevated" post="in 17% 28.2% Hypotension (1%) HRâ€‰&amp;gt;â€‰125â€‰bpm (1%) Guo et"/>
 <result pre="Zhou et al22 191 HFÂ (23%) Elevated in 17% 28.2%" exact="Hypotension" post="(1%) HRâ€‰&amp;gt;â€‰125â€‰bpm (1%) Guo et al21 187 VT/VF (5.9%)"/>
 <result pre="Hypotension (1%) HRâ€‰&amp;gt;â€‰125â€‰bpm (1%) Guo et al21 187 VT/VF (5.9%)" exact="Elevated" post="in 27.8% 23% Abbreviations: CO, cardiac output; ECG, electrocardiogram;"/>
 <result pre="Abbreviations: CO, cardiac output; ECG, electrocardiogram; EF, ejection fraction; HF," exact="heart" post="failure; HR, heart rate; MERSâ€�CoV, Middle East respiratory syndrome"/>
 <result pre="output; ECG, electrocardiogram; EF, ejection fraction; HF, heart failure; HR," exact="heart" post="rate; MERSâ€�CoV, Middle East respiratory syndrome coronavirus; ND, not"/>
 <result pre="fraction; HF, heart failure; HR, heart rate; MERSâ€�CoV, Middle East" exact="respiratory" post="syndrome coronavirus; ND, not disclosed; pt, patient; LVEF, left"/>
 <result pre="HF, heart failure; HR, heart rate; MERSâ€�CoV, Middle East respiratory" exact="syndrome" post="coronavirus; ND, not disclosed; pt, patient; LVEF, left ventricular"/>
 <result pre="patient; LVEF, left ventricular ejection fraction; TTE, transthoracic echocardiogram; RBBB," exact="right bundle branch block;" post="Rev, reversible; SARSâ€�CoV, severe acute respiratory syndromeâ€�coronavirus; SVT, supra"/>
 <result pre="echocardiogram; RBBB, right bundle branch block; Rev, reversible; SARSâ€�CoV, severe" exact="acute" post="respiratory syndromeâ€�coronavirus; SVT, supra ventricular tachycardia; VF, ventricular fibrillation;"/>
 <result pre="RBBB, right bundle branch block; Rev, reversible; SARSâ€�CoV, severe acute" exact="respiratory" post="syndromeâ€�coronavirus; SVT, supra ventricular tachycardia; VF, ventricular fibrillation; VT,"/>
 <result pre="block; Rev, reversible; SARSâ€�CoV, severe acute respiratory syndromeâ€�coronavirus; SVT, supra" exact="ventricular tachycardia;" post="VF, ventricular fibrillation; VT, ventricular tachycardia. (C) John Wiley"/>
 <result pre="SARSâ€�CoV, severe acute respiratory syndromeâ€�coronavirus; SVT, supra ventricular tachycardia; VF," exact="ventricular fibrillation;" post="VT, ventricular tachycardia. (C) John Wiley &amp;amp; Sons, Ltd.,"/>
 <result pre="respiratory syndromeâ€�coronavirus; SVT, supra ventricular tachycardia; VF, ventricular fibrillation; VT," exact="ventricular tachycardia." post="(C) John Wiley &amp;amp; Sons, Ltd., This article is"/>
 <result pre="Ltd., This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
 <result pre="elevated troponin T (TnT) levels developed more frequently complications as" exact="acute" post="respiratory distress syndrome (57.7% vsÂ 11.9%), malignant VAs (11.5%"/>
 <result pre="troponin T (TnT) levels developed more frequently complications as acute" exact="respiratory" post="distress syndrome (57.7% vsÂ 11.9%), malignant VAs (11.5% vsÂ"/>
 <result pre="(TnT) levels developed more frequently complications as acute respiratory distress" exact="syndrome" post="(57.7% vsÂ 11.9%), malignant VAs (11.5% vsÂ 5.2%), acute"/>
 <result pre="frequently complications as acute respiratory distress syndrome (57.7% vsÂ 11.9%)," exact="malignant" post="VAs (11.5% vsÂ 5.2%), acute coagulopathy (65.8% vsÂ 20.0%),"/>
 <result pre="distress syndrome (57.7% vsÂ 11.9%), malignant VAs (11.5% vsÂ 5.2%)," exact="acute" post="coagulopathy (65.8% vsÂ 20.0%), and acute kidney injury (36.8%"/>
 <result pre="syndrome (57.7% vsÂ 11.9%), malignant VAs (11.5% vsÂ 5.2%), acute" exact="coagulopathy" post="(65.8% vsÂ 20.0%), and acute kidney injury (36.8% vsÂ"/>
 <result pre="VAs (11.5% vsÂ 5.2%), acute coagulopathy (65.8% vsÂ 20.0%), and" exact="acute" post="kidney injury (36.8% vsÂ 4.7%), compared with those with"/>
 <result pre="(11.5% vsÂ 5.2%), acute coagulopathy (65.8% vsÂ 20.0%), and acute" exact="kidney injury" post="(36.8% vsÂ 4.7%), compared with those with normal TnT"/>
 <result pre="due to the excess of variable for only 54 events.22" exact="Acute" post="myocarditis, as well as VAs might represent the first"/>
 <result pre="at the time of infection. Another relevant aspect of COVIDâ€�19" exact="infection" post="is that early diagnosis can be confounded in patients"/>
 <result pre="is that early diagnosis can be confounded in patients with" exact="chronic" post="cardiac conditions, once the most frequent symptoms, like fatigue"/>
 <result pre="National Health Commission of China (NHC) reported that among SARSâ€�CoVâ€�2" exact="infection" post="confirmed cases, cardiovascular symptoms were the first presentation in"/>
 <result pre="of China (NHC) reported that among SARSâ€�CoVâ€�2 infection confirmed cases," exact="cardiovascular" post="symptoms were the first presentation in some patients. The"/>
 <result pre="the first presentation in some patients. The problem behind these" exact="atypical" post="presentations is that patients suffering from heart palpitations and"/>
 <result pre="problem behind these atypical presentations is that patients suffering from" exact="heart" post="palpitations and chest tightness rather than respiratory symptoms, such"/>
 <result pre="atypical presentations is that patients suffering from heart palpitations and" exact="chest" post="tightness rather than respiratory symptoms, such as fever and"/>
 <result pre="patients suffering from heart palpitations and chest tightness rather than" exact="respiratory" post="symptoms, such as fever and cough, had a delayed"/>
 <result pre="among the people who died from COVIDâ€�19, 11.8% had substantial" exact="heart" post="damage, with elevated troponin I levels or cardiac arrest"/>
 <result pre="had substantial heart damage, with elevated troponin I levels or" exact="cardiac arrest" post="during hospitalization.26 Explanatory theories regarding COVIDâ€�19 cardiovascular affection postulate"/>
 <result pre="levels or cardiac arrest during hospitalization.26 Explanatory theories regarding COVIDâ€�19" exact="cardiovascular" post="affection postulate that chronic cardiovascular diseases may become unstable"/>
 <result pre="during hospitalization.26 Explanatory theories regarding COVIDâ€�19 cardiovascular affection postulate that" exact="chronic" post="cardiovascular diseases may become unstable in the setting of"/>
 <result pre="hospitalization.26 Explanatory theories regarding COVIDâ€�19 cardiovascular affection postulate that chronic" exact="cardiovascular" post="diseases may become unstable in the setting of a"/>
 <result pre="cardiovascular diseases may become unstable in the setting of a" exact="viral infection" post="as a consequence of the imbalance between the infectionâ€�induced"/>
 <result pre="diseases may become unstable in the setting of a viral" exact="infection" post="as a consequence of the imbalance between the infectionâ€�induced"/>
 <result pre="inflammatory response and myocardial damage, could raise the risk of" exact="acute" post="coronary syndromes, HF, and arrhythmias. The deleterious SARSâ€�CoVâ€�2 infection"/>
 <result pre="of acute coronary syndromes, HF, and arrhythmias. The deleterious SARSâ€�CoVâ€�2" exact="infection" post="myocardial effects could also be perpetuated by the prompt"/>
 <result pre="perpetuated by the prompt and severe downregulation of myocardial and" exact="pulmonary" post="ACE2 pathways, thereby mediating myocardial inflammation, lung edema, and"/>
 <result pre="pulmonary ACE2 pathways, thereby mediating myocardial inflammation, lung edema, and" exact="acute" post="respiratory failure.27 ACE2 is widely expressed not only in"/>
 <result pre="ACE2 pathways, thereby mediating myocardial inflammation, lung edema, and acute" exact="respiratory" post="failure.27 ACE2 is widely expressed not only in the"/>
 <result pre="expressed not only in the lungs but also in the" exact="cardiovascular" post="system and, therefore, ACE2â€�related signaling pathways might even have"/>
 <result pre="therefore, ACE2â€�related signaling pathways might even have a role in" exact="heart" post="injury. Other proposed mechanisms of myocardial injury include a"/>
 <result pre="include a cytokine storm triggered by an imbalanced response by" exact="type 1" post="and 2 Tâ€�helper cells,20, 28 strong interferonâ€�mediated immunopathological events,29"/>
 <result pre="and 2 Tâ€�helper cells,20, 28 strong interferonâ€�mediated immunopathological events,29 and" exact="respiratory" post="dysfunction and hypoxemia caused by COVIDâ€�19, resulting in damage"/>
 <result pre="in this context, would further augment the possibility of adverse" exact="cardiovascular" post="events. Regarding hypoxemia caused by COVIDâ€�19, it is relevant"/>
 <result pre="it is relevant to highlight that this condition can trigger" exact="atrial fibrillation," post="which is the most common arrhythmia among elderly individuals,"/>
 <result pre="condition can trigger atrial fibrillation, which is the most common" exact="arrhythmia" post="among elderly individuals, and that atrial fibrillation can become"/>
 <result pre="is the most common arrhythmia among elderly individuals, and that" exact="atrial fibrillation" post="can become persistent even before pulmonary improvement. Furthermore, the"/>
 <result pre="the most common arrhythmia among elderly individuals, and that atrial" exact="fibrillation" post="can become persistent even before pulmonary improvement. Furthermore, the"/>
 <result pre="individuals, and that atrial fibrillation can become persistent even before" exact="pulmonary" post="improvement. Furthermore, the systemic inflammatory response would make anticoagulation"/>
 <result pre="fibrillation can become persistent even before pulmonary improvement. Furthermore, the" exact="systemic" post="inflammatory response would make anticoagulation therapy for atrial fibrillation"/>
 <result pre="Furthermore, the systemic inflammatory response would make anticoagulation therapy for" exact="atrial fibrillation" post="very complex.30 1.3 Chloroquine and hydroxychloroquine side effects on"/>
 <result pre="the systemic inflammatory response would make anticoagulation therapy for atrial" exact="fibrillation" post="very complex.30 1.3 Chloroquine and hydroxychloroquine side effects on"/>
 <result pre="fibrillation very complex.30 1.3 Chloroquine and hydroxychloroquine side effects on" exact="cardiovascular" post="system Another essential aspect to be discussed is about"/>
 <result pre="system Another essential aspect to be discussed is about chloroquine" exact="cardiovascular" post="side effects since this is one of the promising"/>
 <result pre="is fascicular block, which can lead to advanced types of" exact="atrioventricular block," post="generally associated with syncope.36 HCQ can also induce QT"/>
 <result pre="shown to cause delayed rates in depolarization leading to decreased" exact="heart" post="rates. These findings may correlate with a proposed mechanism"/>
 <result pre="HCQ proarrhythmic risk must be monitored in patients with underlying" exact="cardiovascular" post="or renal disorders, and high caution should be posed"/>
 <result pre="imbalance, dysrhythmias or concurrent use of QTcâ€�prolonging drugs.38 2 CONCLUSION" exact="Acute" post="lung injury is a common problem in patients with"/>
 <result pre="mortality. However, increasing clinical and epidemiological evidence suggests that COVIDâ€�19" exact="infection" post="is associated with myocardial injury and arrhythmic complications. Even"/>
 <result pre="of COVIDâ€�19 arrhythmogenic effects has yet not been reported, close" exact="cardiovascular" post="surveillance is advisable, particularly in patients with more severe"/>
 <result pre="Since many medications are being used empirically to treat the" exact="infection" post="and/or symptoms, there is a need to increase awareness"/>
 <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€�infected" exact="pneumonia" post="in wuhan, China. JAMA. 202010.1001/jama.2020.1585 3HuH, MaF, WeiX, FangY.Coronavirus"/>
 <result pre="in wuhan, China. JAMA. 202010.1001/jama.2020.1585 3HuH, MaF, WeiX, FangY.Coronavirus fulminant" exact="myocarditis" post="saved with glucocorticoid and human immunoglobulin. Eur Heart J."/>
 <result pre="FangY.Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur" exact="Heart" post="J. 202010.1093/eurheartj/ehaa190 4SellersSA, HaganRS, HaydenFG, FischerWA2nd. The hidden burden"/>
 <result pre="Viruses. 2017;11:372â€�393.28745014 5AlexanderLK, SmallJD, EdwardsS, BaricRS. An experimental model for" exact="dilated cardiomyopathy" post="after rabbit coronavirus infection. J Infect Dis. 1992;166:978â€�985.1328411 6XiongTY,"/>
 <result pre="2017;11:372â€�393.28745014 5AlexanderLK, SmallJD, EdwardsS, BaricRS. An experimental model for dilated" exact="cardiomyopathy" post="after rabbit coronavirus infection. J Infect Dis. 1992;166:978â€�985.1328411 6XiongTY,"/>
 <result pre="J Infect Dis. 1992;166:978â€�985.1328411 6XiongTY, RedwoodS, PrendergastB, ChenM.Coronaviruses and the" exact="cardiovascular" post="system: acute and longâ€�term implications. Eur Heart J. 202010.1093/eurheartj/ehaa231"/>
 <result pre="Dis. 1992;166:978â€�985.1328411 6XiongTY, RedwoodS, PrendergastB, ChenM.Coronaviruses and the cardiovascular system:" exact="acute" post="and longâ€�term implications. Eur Heart J. 202010.1093/eurheartj/ehaa231 7YuCM, WongRS,"/>
 <result pre="ChenM.Coronaviruses and the cardiovascular system: acute and longâ€�term implications. Eur" exact="Heart" post="J. 202010.1093/eurheartj/ehaa231 7YuCM, WongRS, WuEB, et al. Cardiovascular complications"/>
 <result pre="202010.1093/eurheartj/ehaa231 7YuCM, WongRS, WuEB, et al. Cardiovascular complications of severe" exact="acute" post="respiratory syndrome. Postgrad Med J. 2006;82:140â€�144.16461478 8LauST, YuWC, MokNS,"/>
 <result pre="7YuCM, WongRS, WuEB, et al. Cardiovascular complications of severe acute" exact="respiratory" post="syndrome. Postgrad Med J. 2006;82:140â€�144.16461478 8LauST, YuWC, MokNS, TsuiPT,"/>
 <result pre="Postgrad Med J. 2006;82:140â€�144.16461478 8LauST, YuWC, MokNS, TsuiPT, TongWL, ChengSW." exact="Tachycardia" post="amongst subjects recovering from severe acute respiratory syndrome (SARS)."/>
 <result pre="MokNS, TsuiPT, TongWL, ChengSW. Tachycardia amongst subjects recovering from severe" exact="acute" post="respiratory syndrome (SARS). Int J Cardiol. 2005;100:167â€�169.15820302 9PanSF, ZhangHY,"/>
 <result pre="TsuiPT, TongWL, ChengSW. Tachycardia amongst subjects recovering from severe acute" exact="respiratory" post="syndrome (SARS). Int J Cardiol. 2005;100:167â€�169.15820302 9PanSF, ZhangHY, LiCS,"/>
 <result pre="TongWL, ChengSW. Tachycardia amongst subjects recovering from severe acute respiratory" exact="syndrome" post="(SARS). Int J Cardiol. 2005;100:167â€�169.15820302 9PanSF, ZhangHY, LiCS, WangC.Cardiac"/>
 <result pre="J Cardiol. 2005;100:167â€�169.15820302 9PanSF, ZhangHY, LiCS, WangC.Cardiac arrest in severe" exact="acute" post="respiratory syndrome: analysis of 15 cases. Zhonghua Jie He"/>
 <result pre="Cardiol. 2005;100:167â€�169.15820302 9PanSF, ZhangHY, LiCS, WangC.Cardiac arrest in severe acute" exact="respiratory" post="syndrome: analysis of 15 cases. Zhonghua Jie He He"/>
 <result pre="He He Hu Xi Za Zhi. 2003;26:602â€�605.14633442 10collab: Centers for" exact="Disease" post="Control and Prevention (CDC) . Update: severe respiratory illness"/>
 <result pre="Centers for Disease Control and Prevention (CDC) . Update: severe" exact="respiratory" post="illness associated with Middle East respiratory syndrome coronavirus (MERSâ€�CoV)â€�worldwide,"/>
 <result pre="(CDC) . Update: severe respiratory illness associated with Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV)â€�worldwide, 2012â€�2013. MMWR Morb Mortal Wkly Rep."/>
 <result pre=". Update: severe respiratory illness associated with Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV)â€�worldwide, 2012â€�2013. MMWR Morb Mortal Wkly Rep. 2013;62:480â€�483.23760190"/>
 <result pre="MMWR Morb Mortal Wkly Rep. 2013;62:480â€�483.23760190 11MaslowJN. Vaccines for emerging" exact="infectious" post="diseases: lessons from MERS coronavirus and Zika virus. Hum"/>
 <result pre="2017;13:2918â€�2930.28846484 12BadawiA, RyooSG. Prevalence of comorbidities in the Middle East" exact="respiratory" post="syndrome coronavirus (MERSâ€�CoV): a systematic review and metaâ€�analysis. Int"/>
 <result pre="12BadawiA, RyooSG. Prevalence of comorbidities in the Middle East respiratory" exact="syndrome" post="coronavirus (MERSâ€�CoV): a systematic review and metaâ€�analysis. Int J"/>
 <result pre="Clinical aspects and outcomes of 70 patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a singleâ€�center experience in Saudi Arabia."/>
 <result pre="aspects and outcomes of 70 patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a singleâ€�center experience in Saudi Arabia. Int"/>
 <result pre="14Alâ€�AbdallatMM, PayneDC, AlqasrawiS, et al. Hospitalâ€�associated outbreak of Middle East" exact="respiratory" post="syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin"/>
 <result pre="PayneDC, AlqasrawiS, et al. Hospitalâ€�associated outbreak of Middle East respiratory" exact="syndrome" post="coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect"/>
 <result pre="serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014;59:1225â€�1233.24829216 15AlhogbaniT.Acute" exact="myocarditis" post="associated with novel Middle East respiratory syndrome coronavirus. Ann"/>
 <result pre="Infect Dis. 2014;59:1225â€�1233.24829216 15AlhogbaniT.Acute myocarditis associated with novel Middle East" exact="respiratory" post="syndrome coronavirus. Ann Saudi Med. 2016;36:78â€�80.26922692 16NguyenJL, YangW, ItoK,"/>
 <result pre="Dis. 2014;59:1225â€�1233.24829216 15AlhogbaniT.Acute myocarditis associated with novel Middle East respiratory" exact="syndrome" post="coronavirus. Ann Saudi Med. 2016;36:78â€�80.26922692 16NguyenJL, YangW, ItoK, MatteTD,"/>
 <result pre="Med. 2016;36:78â€�80.26922692 16NguyenJL, YangW, ItoK, MatteTD, ShamanJ, KinneyPL. Seasonal influenza" exact="infections" post="and cardiovascular disease mortality. AMA Cardiol. 2016;1:274â€�281. 17MadjidM, ConnollyAT,"/>
 <result pre="16NguyenJL, YangW, ItoK, MatteTD, ShamanJ, KinneyPL. Seasonal influenza infections and" exact="cardiovascular disease" post="mortality. AMA Cardiol. 2016;1:274â€�281. 17MadjidM, ConnollyAT, NabutovskyY, Safaviâ€�NaeiniP, RazaviM,"/>
 <result pre="YangW, ItoK, MatteTD, ShamanJ, KinneyPL. Seasonal influenza infections and cardiovascular" exact="disease" post="mortality. AMA Cardiol. 2016;1:274â€�281. 17MadjidM, ConnollyAT, NabutovskyY, Safaviâ€�NaeiniP, RazaviM,"/>
 <result pre="Cardiol. 2019;124:44â€�50.31047651 18AngLW, YapJ, LeeV, et al. Influenzaâ€�associated hospitalizations for" exact="cardiovascular" post="diseases in the tropics. Am J Epidemiol. 2017;186:202â€�209.28338806 19ModinD,"/>
 <result pre="Epidemiol. 2017;186:202â€�209.28338806 19ModinD, JÃ¸rgensenME, GislasonG, et al. Influenza vaccine in" exact="heart" post="failure. Circulation. 2019;139:575â€�586.30586760 20HuangC, WangY, LiX, et al. Clinical"/>
 <result pre="al. Cardiovascular implications of fatal outcomes of patients with coronavirus" exact="disease" post="2019 (COVIDâ€�19). JAMA Cardiol. 202010.1001/jamacardio.2020.1017 22ZhouF, YuT, DuR, et"/>
 <result pre="et al. Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVIDâ€�19 in Wuhan, China: a retrospective cohort"/>
 <result pre="FuC, et al. Left ventricular performance in patients with severe" exact="acute" post="respiratory syndrome: a 30â€�day echocardiographic followâ€�up study. Circulation. 2003;108:1798â€�1803.14504188"/>
 <result pre="et al. Left ventricular performance in patients with severe acute" exact="respiratory" post="syndrome: a 30â€�day echocardiographic followâ€�up study. Circulation. 2003;108:1798â€�1803.14504188 24HarrisJE,"/>
 <result pre="ShahPJ, KorimilliV, WinH.Frequency of troponin elevations in patients with influenza" exact="infection" post="during the 2017â€�2018 influenza season. Int J Cardiol Heart"/>
 <result pre="influenza infection during the 2017â€�2018 influenza season. Int J Cardiol" exact="Heart" post="Vasc. 2019;22:145â€�147.30740511 25YangJ, ZhengY, GouX, et al. Prevalence of"/>
 <result pre="J Infect Dis. 202010.1016/j.ijid.2020.03.017 26ZhengYY, MaYT, ZhangJY, XieX.COVIDâ€�19 and the" exact="cardiovascular" post="system. Nat Rev Cardiol. 202010.1038/s41569-020-0360-5 27OuditGY, KassiriZ, JiangC, et"/>
 <result pre="WuAK, et al. Plasma inflammatory cytokines and chemokines in severe" exact="acute" post="respiratory syndrome. Clin Exp Immunol. 2004;136:95â€�103.15030519 29CameronMJ, Bermejoâ€�MartinJF, DaneshA,"/>
 <result pre="et al. Plasma inflammatory cytokines and chemokines in severe acute" exact="respiratory" post="syndrome. Clin Exp Immunol. 2004;136:95â€�103.15030519 29CameronMJ, Bermejoâ€�MartinJF, DaneshA, MullerMP,"/>
 <result pre="2004;136:95â€�103.15030519 29CameronMJ, Bermejoâ€�MartinJF, DaneshA, MullerMP, KelvinDJ. Human immunopathogenesis of severe" exact="acute" post="respiratory syndrome (SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An acute"/>
 <result pre="29CameronMJ, Bermejoâ€�MartinJF, DaneshA, MullerMP, KelvinDJ. Human immunopathogenesis of severe acute" exact="respiratory" post="syndrome (SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An acute respiratory"/>
 <result pre="Bermejoâ€�MartinJF, DaneshA, MullerMP, KelvinDJ. Human immunopathogenesis of severe acute respiratory" exact="syndrome" post="(SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An acute respiratory infection"/>
 <result pre="severe acute respiratory syndrome (SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An" exact="acute" post="respiratory infection runs into the most common noncommunicable epidemicâ€&quot;COVIDâ€�19"/>
 <result pre="acute respiratory syndrome (SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An acute" exact="respiratory" post="infection runs into the most common noncommunicable epidemicâ€&quot;COVIDâ€�19 and"/>
 <result pre="respiratory syndrome (SARS). Virus Res. 2008;133:13â€�19.17374415 30YangC, JinZ.An acute respiratory" exact="infection" post="runs into the most common noncommunicable epidemicâ€&quot;COVIDâ€�19 and cardiovascular"/>
 <result pre="respiratory infection runs into the most common noncommunicable epidemicâ€&quot;COVIDâ€�19 and" exact="cardiovascular" post="diseases. JAMA Cardiol. 202010.1001/jamacardio.2020.0934 31RatliffNB, EstesML, McMahonJT, MylesJL. Chloroquineâ€�induced"/>
 <result pre="cardiomyopathy. Arch Pathol Lab Med. 1988;112:578. 32SeshadriMS, JohnL, VarkeyK, KoshyTS." exact="Ventricular" post="tachycardia in a patient on dehydroemetine and chloroquine for"/>
 <result pre="Med J Aust. 1979;1:406â€�407.38383 33FauchierJP, FauchierL, BabutyD, BreuillacJC, CosnayP, RouesnelP.Drugâ€�induced" exact="ventricular tachycardia." post="Arch Mal Coeur Vaiss. 1993;86:757â€�767.8267504 34Siqueiraâ€�BatistaR, Ramos JÃºniorAN, PessanhaBS,"/>
 <result pre="Can J Cardiolo. 1988;4:295â€�300. 36VernyC, de GennesC, SebastienP, et al." exact="Heart" post="conduction disorders in longâ€�term treatment with chloroquine: two new"/>
 <result pre="Presse Med. 1992;2:800â€�804. 37CapelRA, HerringN, KallaM, et al. Hydroxychloroquine reduces" exact="heart" post="rate by modulating the hyperpolarizationâ€�activated current if: novel electrophysiological"/>
 <result pre="the hyperpolarizationâ€�activated current if: novel electrophysiological insights and therapeutic potential." exact="Heart" post="Rhythm. 2015;12:2186â€�2194.26025323 38O'LaughlinJP, MehtaPH, WongBC. Life threatening severe QTc"/>
 <result pre="MehtaPH, WongBC. Life threatening severe QTc prolongation in patient with" exact="systemic" post="lupus erythematosus due to hydroxychloroquine. Case Rep Cardiol. 2016:4626279.27478650"/>
 <result pre="WongBC. Life threatening severe QTc prolongation in patient with systemic" exact="lupus erythematosus" post="due to hydroxychloroquine. Case Rep Cardiol. 2016:4626279.27478650 39LeeN, HuiD,"/>
 <result pre="39LeeN, HuiD, WuA, et al. A major outbreak of severe" exact="acute" post="respiratory syndrome in Hong Kong. N Engl J Med."/>
 <result pre="HuiD, WuA, et al. A major outbreak of severe acute" exact="respiratory" post="syndrome in Hong Kong. N Engl J Med. 2003;348:1986â€�1994.12682352"/>
 <result pre="WuA, et al. A major outbreak of severe acute respiratory" exact="syndrome" post="in Hong Kong. N Engl J Med. 2003;348:1986â€�1994.12682352 40BoothCM,"/>
 <result pre="area. JAMA. 2003;289:2801â€�2809.12734147 41Alâ€�TawfiqJA, HinediK, GhandourJ, et al. Middle East" exact="respiratory" post="syndrome coronavirus: a caseâ€�control study of hospitalized patients. Clin"/>
 <result pre="JAMA. 2003;289:2801â€�2809.12734147 41Alâ€�TawfiqJA, HinediK, GhandourJ, et al. Middle East respiratory" exact="syndrome" post="coronavirus: a caseâ€�control study of hospitalized patients. Clin Infect"/>
 <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive study."/>
 <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
 <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive study. Lancet Infect Dis."/>
 <result pre="study. Lancet Infect Dis. 2013;13:752â€�761.23891402 44InciardiRM, LupiL, ZacconeG, et al." exact="Cardiac" post="involvement in a patient with coronavirus disease 2019 (COVIDâ€�19)."/>
 <result pre="ZacconeG, et al. Cardiac involvement in a patient with coronavirus" exact="disease" post="2019 (COVIDâ€�19). JAMA Cardiol. 202010.1001/jamacardio.2020.1096"/>
</results>
